Sakar Healthcare surges after receiving marketing authorization in EU for its oncology product
Sakar Healthcare jumped 4.65% to Rs 344.20 after the company announced the receipt of second marketing authorization (MA) of oncology injection (product registration) for the European Union (EU).
The companys dossier compiled under EU guidelines have fetched this second approval in continuation to the journey of their research-driven API-integrated EU GMP approved oncology formulation manufacturing unit.
While the earlier product intends to treating breast cancer, non-small cell lung cancer and prostate cancer, this second one is for treating colorectal cancer; both are widely prevalent type of cancers.
"Strategically the second MA now widens the door to export and commercialise injection products to the European countries, with the first MA that received approval in April-2025 is in process of its FIRST commercial supply, Sakar Healthcare stated.
It further said that with another few products (mix of liquid, lyophilised injections and oral solids) presently under registration in the EU, the company expects the grant of these MAs one-by-one within next few months.
These MAs will speed up the export of multiple oncology products to the EU region manufactured at Sakars state-of-the-art vertically integrated oncology product manufacturing site.
Sakar Healthcare manufactures pharmaceutical formulations in the form of liquid injectables, tablets/ capsules, oral liquid syrups, dry powder injections and syrups. The company manufactures generic formulations in 24 therapeutic categories, such as antibiotics, cough preparations, vitamins and mineral supplements, among others. Also, the company entered the oncology drugs segment with units for oncology formulations, APIs and injectables.
The company's consolidated net profit surged 84.62% to Rs 5.76 crore as revenues increased by 16.67% to Rs 50.24 crore in Q4 FY25 as compared with Q4 FY24.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
25 minutes ago
- Hans India
Welspun Living and NSDC join hands to upskill and empower Bharat's Next Gen Textile Workforce
Welspun Living Limited (WLL), a global leader in home textiles and a part of India's fastest growing global conglomerate Welspun World, has entered into a strategic partnership with the National Skill Development Corporation (NSDC) to launch a large-scale skilling and employment initiative focused on operator-level roles in the textile sector. The partnership will help in fostering industry partnerships to address skill gaps and enhance employability. The scheme jointly launched by the Union Minister of State (Independent Charge) for Skill Development and Entrepreneurship, Jayant Chaudhary and Chief Minister of Mizoram Pu Lalduhoma. The event also saw participation from key government leaders including Lalnghinglova Hmar, Minister of State, Labour, Employment and Skill Development & Entrepreneurship, Government of Mizoram; K Sapdanga, Hon'ble Minister for Home, Government of Mizoram; Maotoshi Longkumer, Adviser for Skill Development, Employment, Labour & Excise, Government of Nagaland; G Madhumita Das, Additional Secretary and Financial Advisor, Ministry of Skill Development and Entrepreneurship, Government of India; and Shreeshail Malge, Joint Secretary, MSDE. They appreciated the joint effort by Welspun and NSDC, highlighting the importance of such initiatives in creating jobs and building skills, especially in the North-East and other underserved regions. This initiative covers training, travel, and stipends for the trainees at an approximate cost of Rs 42,500 per trainee during the training period. The total investment for the program amounts to Rs 4.25 crore. The partnership aims to train and certify 1,000 candidates in its pilot phase, with at least 50% women participation, particularly from underrepresented regions such as the North-Eastern states and Uttarakhand. The program is designed to create a sustainable talent pipeline for India's textile manufacturing sector while advancing gender and regional equity. The program will be conducted at Welspun's state of art facilities in Anjar and Vapi, Gujarat combined of: 120 hours of classroom-based training 210 hours of On-the-Job Training (OJT). Candidates will be trained in key technical areas such as machine handling, production processes, quality control, safety protocols, and soft skills. Upon successful completion, all trainees will receive a joint certification from NSDC and Welspun and be assured of captive employment within Welspun's textile operations. 'At Welspun, we believe that women are not just participants but powerful catalysts in shaping the future of India's textile industry,' said Dipali Goenka, MD & CEO, Welspun Living Limited. 'This partnership reflects our commitment to inclusive and sustainable growth. By focusing on women from North east & Uttarakhand, we are not only bridging skill gaps but also unlocking pathways to economic independence, self-worth, and generational impact.' Rajesh Jain, Chief Human Resources Officer, Welspun Living Limited, added, 'Skill development is not just about employment, it is about creating opportunities and empowering people with the ability to transform their futures. Through our collaboration with NSDC, we aim to create a more inclusive and future-ready textile workforce, and contribute to boost economic growth' This initiative reflects Welspun's LITE philosophy-Learning, Innovation, Trust/Talent, and Endurance. Earlier this year, the company marked its 38th Founders Day with the theme 'The Unstoppable W,' celebrating the spirit of inclusive growth. The skilling partnership builds on this vision by equipping individuals, especially women, to thrive in the future of textiles.
Hans India
25 minutes ago
- Hans India
India moves up among top global destinations for FDI in 2024: UNCTAD
New Delhi: India moved up among top global destinations for foreign direct investment (FDI) in 2024, remaining the dominant recipient in South Asia and accounting for the vast majority of FDI inflows, a United Nations Conference on Trade and Development (UNCTAD) report said on Thursday. Despite a marginal dip in inflows at $27.6 billion, India climbed up to 15th place globally in 2024, from 16th position in 2023 when it received $28.1 billion in FDI, according to the UNCTAD's 'World Investment Report 2025'. "While project numbers increased in most regions, only a few countries saw a significant rise in the value of new project announcements. India stood out with projected capital expenditures up by more than a quarter to $110 billion, almost a third of the total in Asia," the report mentioned. There was a notable increase in greenfield project announcements, where India ranked fourth with 1,080 greenfield projects announced in 2024. Greenfield projects have become an important source of investment in the digital economy in the developing world. The number of greenfield projects announced by Indian investors increased by 20 per cent, placing India among the world's top 10 investor countries, the report noted. The country was also among the top five economies in terms of international project finance deals, securing 97 such transactions. The value and number of greenfield projects rose in developed economies but fell in developing countries, reversing the trend observed in 2023. "In India, semiconductor and basic metals projects contributed to the rise in manufacturing activity," said the report. Energy and gas supply retained its position as the top sector by project value, accounting for 14 per cent of the total. The sector shows the highest average project size at $584 million, with a prevalence of utility-scale developments, including solar farms, wind parks, liquefied natural gas terminals and power transmission infrastructure. "The sector saw moderate growth in value (+12 per cent), driven by national energy transition plans in India, Indonesia and Viet Nam, supported by blended finance models and enabling policy frameworks," the UNCTAD report mentioned. Overall, global FDI fell by 11 per cent, marking the second consecutive year of decline and confirming a deepening slowdown in productive capital flows, according to the World Investment Report 2025. Although global FDI rose by 4 per cent in 2024 to $1.5 trillion, the increase is the result of, among other factors, volatile financial conduit flows through several European economies, which often serve as transfer points for investments. "Too many economies are being left behind not for a lack of potential – but because the system still sends capital where it's easiest, not where it's needed," said UN Trade and Development Secretary-General Rebeca Grynspan. "But we can change that. If we align public and private investment with development goals and build trust into the system, domestic and international markets will bring scale, stability and predictability. And today's volatility can become tomorrow's opportunity," Grynspan added.
Time of India
28 minutes ago
- Time of India
Govt announces Rs 10-crore prize for new drug to treat sickle cell disease
The government is awarding Rs 10 crore to develop a sickle cell disease drug. This initiative addresses the disproportionate impact on tribal populations. The goal is to eradicate the disease by 2047. A competition with AIIMS-Delhi will select the best drug proposal. A Centre for Tribal Health will be established. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads The government on Thursday announced an award of Rs 10 crore to develop a drug for the treatment of sickle cell disease , which disproportionately affects India's tribal populations. Sickle cell disease is a group of inherited blood disorders that affect haemoglobin , causing red blood cells to become sickle-shaped and block the blood flow, which can lead to serious complications such as stroke, eye problems and Minister Narendra Modi launched the National Sickle Cell Anaemia Eradication Mission on July 1, 2023, with the aim of eradicating the disease by 2047. The government aims to screen seven crore people up to 40 years of age as part of the an event to mark World Sickle Cell Day here, Union Minister of State for Tribal Affairs Durgadas Uikey announced the institution of the Bhagwan Birsa Munda Prize for the development of a drug to treat the minister said there is only one drug available as of now for the management of the disease. There is currently no option to select a drug from a range of alternatives based on the patient's body conditions and severity of the said this problem is worsened in special situations like pregnancy or the presence of other serious medical conditions. Therefore, there is an urgent need to develop a new tribal affairs ministry, in collaboration with the AIIMS-Delhi, will undertake a competition for the development of the drug. The selected proposal will be funded up to Rs 10 crore, Uikey also said the ministry will establish a Centre for Tribal Health and Research Institute under the centre will also have outpatient and inpatient facilities for providing the highest-quality medical care to tribal people. Provisions for seamless referrals from peripheral hospitals in tribal-dominated areas will be explored, he centre will also guide the government in policy minister said a postgraduate course in tribal medicine will also be will help address the long-standing health inequities faced by tribal communities, who often remain underserved due to geographical, socio-cultural and systemic barriers, he specialised course will be designed to develop a cadre of medical professionals with contextual knowledge, clinical skills and public health competencies tailored to tribal settings.
